3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Acute Lymphoblastic Leukemia (ALL): new trials by email Literature Review of Acute Lymphoblastic Leukemia (ALL) trials Research Report on Acute Lymphoblastic Leukemia (ALL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS NiCord® (omidubicel), Cord Blood Unit - Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Completed | Gamida Cell ltd | 125 | 2016-12-16 | 2026-02-25 |
| International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 SR-A + Epratuzumab, SR-B + Epratuzumab - Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Completed | Charite University, Berlin, Germany | 700 | 2014-05-01 | 2024-02-09 |
| Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL Glucarpidase - Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Completed | Nordic Society for Pediatric Hematology and Oncology | 47 | 2008-07-01 | 2018-09-28 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Hematologic Neoplasms (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Myelodysplastic Syndromes (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Leukemia, Myeloid (1) · Myeloproliferative Disorders (1)
Receptors, Scavenger (1) · epratuzumab (1) · glucarpidase (1)
Charite University, Berlin, Germany (1) · Gamida Cell ltd (1) · Nordic Society for Pediatric Hematology and Oncology (1)
Denmark (2) · Finland (2) · France (2) · Israel (2) · Italy (2) · Netherlands (2) · Norway (2) · Portugal (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Czechia (1) · Germany (1)
Arend von Stackelberg, MD (1) · Jesper Heldrup, M D (1) · Mitchell Horwitz, MD (1)
PMID 27966809, PMID 33811823, PMID 34157093, PMID 37120136, PMID 37341952, PMID 37703995